Perret R - Search Results

1

Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.

Castro-Díaz N, Salaun B, Perret R, Sierro S, Romero JF, Fernández JA, Rubio-Moraga A, Romero P. Castro-Díaz N, et al. Among authors: perret r. Vaccine. 2012 Jan 5;30(2):388-97. doi: 10.1016/j.vaccine.2011.10.080. Epub 2011 Nov 10. Vaccine. 2012. PMID: 22079266

2

Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.

Perret R, Sierro SR, Botelho NK, Corgnac S, Donda A, Romero P. Perret R, et al. Cancer Res. 2013 Nov 15;73(22):6597-608. doi: 10.1158/0008-5472.CAN-13-0875. Epub 2013 Sep 18. Cancer Res. 2013. PMID: 24048821

3

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.

Corgnac S, Perret R, Zhang L, Mach JP, Romero P, Donda A. Corgnac S, et al. Among authors: perret r. J Immunother Cancer. 2014 Nov 18;2(1):39. doi: 10.1186/s40425-014-0039-8. eCollection 2014. J Immunother Cancer. 2014. PMID: 25426294 Free PMC article.

4

Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity.

Sierro SR, Donda A, Perret R, Guillaume P, Yagita H, Levy F, Romero P. Sierro SR, et al. Among authors: perret r. Eur J Immunol. 2011 Aug;41(8):2217-28. doi: 10.1002/eji.201041235. Epub 2011 May 27. Eur J Immunol. 2011. PMID: 21538347 Free article.

5

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P. Dudda JC, et al. Among authors: perret r. Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006. Immunity. 2013. PMID: 23601686 Free PMC article.

6

Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.

Peacey M, Wilson S, Perret R, Ronchese F, Ward VK, Young V, Young SL, Baird MA. Peacey M, et al. Among authors: perret r. Vaccine. 2008 Oct 3;26(42):5334-7. doi: 10.1016/j.vaccine.2008.07.074. Epub 2008 Aug 14. Vaccine. 2008. PMID: 18706958

7

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Corgnac S, Perret R, Derré L, Zhang L, Stirnemann K, Zauderer M, Speiser DE, Mach JP, Romero P, Donda A. Corgnac S, et al. Among authors: perret r. Cancer Immunol Immunother. 2013 Apr;62(4):747-60. doi: 10.1007/s00262-012-1381-7. Epub 2012 Dec 15. Cancer Immunol Immunother. 2013. PMID: 23242316 Free PMC article.

8

Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?

Perret R, Ronchese F. Perret R, et al. Tissue Antigens. 2008 Sep;72(3):187-94. doi: 10.1111/j.1399-0039.2008.01088.x. Epub 2008 Jul 9. Tissue Antigens. 2008. PMID: 18627571 Review.

9

Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.

Perret R, Ronchese F. Perret R, et al. Eur J Immunol. 2008 Oct;38(10):2886-95. doi: 10.1002/eji.200838483. Eur J Immunol. 2008. PMID: 18825745 Free article.

10

Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo.

Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, Hermans IF, Ritchie DS, Yang J, Ronchese F. Andrew KA, et al. Among authors: perret r. J Immunol. 2008 Dec 15;181(12):8356-62. doi: 10.4049/jimmunol.181.12.8356. J Immunol. 2008. PMID: 19050252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters